FDA inspection
Baxalta Belgium Manufacturing SA: FDA inspection ending Jan 21, 2011
FDA inspection 712920 · Official Action Indicated (OAI) · Lessines
Key facts
| Inspection ID | 712920 |
|---|---|
| Firm | Baxalta Belgium Manufacturing SA |
| FEI number | 3002806503 |
| Address | Boulevard Rene Branquart 80 |
| City | Lessines |
| Country | Belgium |
| Fiscal year | 2011 |
| Inspection end date | Jan 21, 2011 |
| Classification | Official Action Indicated (OAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data